✦ LIBER ✦

On optimal regulation of price and R&D with asymmetric information

✍ Scribed by Jean-Christophe Poudou; Lionel Thomas

Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 369 KB
Volume: 14
Category: Article
ISSN: 1434-4750
DOI: 10.1007/s10058-009-0081-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Optimal regulation of technical progress

Optimal regulation of technical progress in natural monopolies with asymmetric information

✍ Uwe Cantner; Thomas Kuhn 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 74 KB

On the microstructure of price determina

On the microstructure of price determination and information aggregation with sequential and asymmetric information arrival in an experimental asset market

✍ Martin Barner; Francesco Feri; Charles R. Plott 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 305 KB

Optimal expansion and design of competen

Optimal expansion and design of competence sets with asymmetric acquiring costs

✍ D. S. Shi; P. L. Yu 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 554 KB

A study on decisions of warranty, pricin

A study on decisions of warranty, pricing, and production with insufficient information

✍ Chih-Chiang Fang; Yeu-Shiang Huang 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 651 KB

It has been well-recognized that a better warranty term offered by the product producer can effectively increase the product sales, but how such the warranty and pricing decisions can be integrated into a marketing strategy with consideration of production planning as well has drawn relatively less

Price, private demand and optimal provis

Price, private demand and optimal provision of public R&D investment: An application to Italian agriculture, 1960–1995

✍ Roberto Esposti; Pierpaolo Pierani 📂 Article 📅 2006 🏛 Springer-Verlag 🌐 English ⚖ 214 KB

Optimal clinical trial design using valu

Optimal clinical trial design using value of information methods with imperfect implementation

✍ Andrew R. Willan; Simon Eckermann 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 167 KB

## Abstract Traditional sample size calculations for randomized clinical trials are based on the tests of hypotheses and depend on somewhat arbitrarily chosen factors, such as type I and II errors rates and the smallest clinically important difference. In response to this, many authors have propose